KKPCF (Kaken Pharmaceutical Co) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KKPCF Kaken Pharmaceutical Co Ltd KKPCF
69 GF Score
Price $26.00
GF Value $25.42
! 2 Warning Signs
View Full Analysis

What is Kaken Pharmaceutical Co Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

KKPCF
69GF Score
Kaken Pharmaceutical Co Ltd KKPCF
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kaken Pharmaceutical Co (KKPCF) Overvalued in 2026?

Based on GuruFocus' analysis, Kaken Pharmaceutical Co stock appears to be overvalued. The current stock price of $26.00 is trading 2.3% above its estimated GF Value™ of $25.42.

Key valuation signals for KKPCF:

  • Interest Received:
  • GF Value™: $25.42 vs. price of $26.00 (2.3% above fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the KKPCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kaken Pharmaceutical Co Business Description

Other Exchanges 4521:Japan
Address 28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JPN, 1138650
Kaken Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
69GF Score

Get the complete analysis for KKPCF

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.00
Price
$25.42
GF Value